Close this search box.

Ethics of early clinical trials in regenerative medicine in transplantation


Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near future. How can first-in-human clinical trials be conducted in a safe and responsible manner? What are ethical points to consider for early clinical trials of regenerative medicine in transplantation? This workshop brings together experts in the fields of regenerative medicine and ethics to discuss these ethical challenges.


Professor Jonathan Kimmelman, McGill University

Director of Biomedical Ethics Unit

Author of Gene Transfer and the Ethics of First-in-Human Trials: Lost in Translation

SHOWCASES OF REGENERATIVE MEDICINE APPLICATIONS Insights from 3 projects funded through EU Horizon 2020

‘Regenerative medicine: From new insights to new applications’

– VANGUARD: Dide de Jongh, Erasmus MC
– OrganTrans: Ary Marsee, Utrecht University
– Brav3: Olalla Iglesias García, University of Navarra



Moderated by Eline Bunnik & Emma Massey, Erasmus MC

Panel members
Jonathan Kimmelman, McGill University
Antonia Cronin, King’s College London
Ekaterine Berishvili, University of Geneva
Anne-Floor de Kanter, Utrecht University
Mariana Pacheco Blanco, Amires S.r.o.
Manuel M. Mazo Vega, University of Navarra

Register online, meeting is open to the public. Attendance is free. Registration is required.


Feb 03 2022


4:00 pm - 6:00 pm

More Info

Register online
Register online